The Ebola virus is a hideous thing. It disrupts both the endothelial cells lining blood vessels and interferes with coagulation, causing massive bleeding - not to mention fever, muscle pain, headache, and the inflammation of the back of the throat. It is one deadly pathogen, for which there exists no decent treatment.
Stanford's Jan Carrette, PhD, is first author of a study, just published in Nature, elucidating a crucial aspect of how the virus gains entry to cells - the first step down the ladder to a dark outcome and, (one hopes) a good place to focus on in a search for therapeutic efficacy against Ebola.
Photo courtesy CDC and is U.S. Government Work
